Immix Biopharma, Inc.

IMMX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001873835

SEC filings (opens in a new tab)

No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Immix Biopharma, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of IMMX: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Q4 2025	Change
Holders	31	67	+36
Shares	2.77M	24.4M	+21.6M (+781.5%)
Value	$5.78M	$127.5M	+$121.7M (+2,105.3%)

New holders (41)

Institutions that held Immix Biopharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to IMMX in Q4 2025
Institution	Shares	Value	% of portfolio
Janus Henderson Group PLC	3,921,568	$20.5M	0.01%
Saturn V Capital Management LLC	2,999,169	$15.7M	2.88%
Eventide Asset Management, LLC	2,549,019	$13.3M	0.21%
Millennium Management LLC	1,659,778	$8.68M	0.01%
Adage Capital Partners GP, L.L.C.	1,500,000	$7.84M	0.01%
Logos Global Management LP	1,000,000	$5.23M	0.35%
Blue Owl Capital Holdings LP	986,240	$5.16M	1.59%
Franklin Resources Inc	980,392	$5.13M	0.00%
Ameriprise Financial Inc	452,147	$2.36M	0.00%
Perceptive Advisors LLC	338,941	$1.77M	0.03%
Burkehill Global Management, LP	294,118	$1.54M	0.10%
KVP Capital Advisors, LP	230,423	$1.21M	1.24%
Goldman Sachs Group Inc	208,370	$1.09M	0.00%
LGT Fund Management Co Ltd.	125,000	$660.0K	0.05%
EAM Investors, LLC	120,856	$632.1K	0.07%
J. Goldman & Co LP	118,261	$618.5K	0.02%
Bank of New York Mellon Corp	98,732	$516.4K	0.00%
Longaeva Partners L.P.	98,040	$512.7K	0.06%
Omers Administration Corp	74,700	$390.7K	0.00%
Virtu Financial LLC	73,791	$386.0K	0.01%
SEI Investments Co	73,570	$384.8K	0.00%
ADAR1 Capital Management, LLC	50,000	$261.5K	0.02%
Qube Research & Technologies Ltd	49,814	$260.5K	0.00%
Barclays PLC	35,000	$183.1K	0.00%
Jump Financial, LLC	33,800	$176.8K	0.00%
Hudson Bay Capital Management LP	33,649	$176.0K	0.00%
Persistent Asset Partners Ltd	31,755	$166.1K	0.08%
Concurrent Investment Advisors, LLC	27,431	$143.5K	0.00%
TritonPoint Partners, LLC	24,526	$128.3K	0.07%
Quadrature Capital Ltd	22,120	$115.7K	0.00%
Squarepoint Ops LLC	21,500	$112.4K	0.00%
Kera Capital Partners, Inc.	13,000	$75.8K	0.01%
Balyasny Asset Management LLC	12,854	$67.2K	0.00%
Tower Research Capital LLC (TRC)	12,163	$63.6K	0.00%
Mathes Company, Inc.	10,650	$56.0K	0.02%
Lighthouse Investment Partners, LLC	10,020	$52.4K	0.00%
Allworth Financial LP	5,716	$29.9K	0.00%
JPMorgan Chase & Co	5,109	$26.7K	0.00%
BNP Paribas Arbitrage, SA	2,700	$14.1K	0.00%
Royal Bank of Canada	995	$5.00K	0.00%
CWM, LLC	1,000	$5.00K	0.00%

Sold out (5)

Institutions that held Immix Biopharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of IMMX in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Tritonpoint Wealth, LLC	24,526	$51.3K
Colony Group, LLC	11,900	$24.9K
MAI Capital Management	2,000	$4.18K
Wells Fargo & Company	330	$690
SRS Capital Advisors, Inc.	34	$71